Chest: BMI has a causal relationship with pulmonary artery pressure, but is not related to the hemodynamic parameters of pulmonary vascular reconstruction.
-
Last Update: 2020-07-29
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
!---- The relationship between obesity and the pathogenesis and severity of pulmonary arterial hypertension (PAH) and pulmonary venous hypertension (PVH) is not yet clearIs body mass index (BMI) associated with pulmonary arterial pressure (PAP) and/or pulmonary vascular remodeling signs? In a recent study published in the journal Chest, the leading journal of respiratory sciences, researchers constructed two BMI genetic risk scores from GWAS aggregatedata and used them for non-overlapping queues of subjects who examined right cardiopulmonary catheterization (RHC) or echocardiogramThe researchers used a BMI risk score (BMI_hpGRS) with the best polymorphism to assess the shared genetic structure of obesity with other characteristics and to associate it with RHC parameters, including pulmonary vascular remodeling markersMendel randomized analysis used a BMI genetic risk score (BMI_sGRS) of high-confidence genetic variation to assess whether a higher BMI caused a higher PAPIn all subjects, directly measured BMI and BMI_hpGRS were positively correlated with pulmonary artery pressure, but not associated with signs of pulmonary vascular remodelingClassification analysis showed that BMI and BMI_hpGRS were PVH-related, but not PAH-relatedBMI_sGRS's Mendel randomization analysis supports higher BMI as the cause of higher constrictal pulmonary arterial pressure (sPAP)Sensitivity analysis showed that the relationship between sPAP and BMI_sGRS persisted when PAH or PVH individuals were excludedIn the echocardiogram queue, BMI and BMI_hpGRS were positively correlated with the estimated PAP and left heart remodeling markersIt can be seen that BMI is the leading factor in the severity of pulmonary hypertension in patients with PAH and PVH, but only related to the pathogenesis of PVH
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.